JP2018528389A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528389A5
JP2018528389A5 JP2017558949A JP2017558949A JP2018528389A5 JP 2018528389 A5 JP2018528389 A5 JP 2018528389A5 JP 2017558949 A JP2017558949 A JP 2017558949A JP 2017558949 A JP2017558949 A JP 2017558949A JP 2018528389 A5 JP2018528389 A5 JP 2018528389A5
Authority
JP
Japan
Prior art keywords
ligand
subunit
homodimer
seq
capillary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558949A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528389A (ja
JP7240812B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/031899 external-priority patent/WO2016183222A1/en
Publication of JP2018528389A publication Critical patent/JP2018528389A/ja
Publication of JP2018528389A5 publication Critical patent/JP2018528389A5/ja
Priority to JP2021092988A priority Critical patent/JP7137663B2/ja
Priority to JP2022139802A priority patent/JP2022171730A/ja
Application granted granted Critical
Publication of JP7240812B2 publication Critical patent/JP7240812B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558949A 2015-05-12 2016-05-11 多量体タンパク質の純度の決定 Active JP7240812B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021092988A JP7137663B2 (ja) 2015-05-12 2021-06-02 多量体タンパク質の純度の決定
JP2022139802A JP2022171730A (ja) 2015-05-12 2022-09-02 多量体タンパク質の純度の決定

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562160341P 2015-05-12 2015-05-12
US62/160,341 2015-05-12
PCT/US2016/031899 WO2016183222A1 (en) 2015-05-12 2016-05-11 Multimeric protein purity determination

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021092988A Division JP7137663B2 (ja) 2015-05-12 2021-06-02 多量体タンパク質の純度の決定

Publications (3)

Publication Number Publication Date
JP2018528389A JP2018528389A (ja) 2018-09-27
JP2018528389A5 true JP2018528389A5 (https=) 2021-01-21
JP7240812B2 JP7240812B2 (ja) 2023-03-16

Family

ID=56072452

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017558949A Active JP7240812B2 (ja) 2015-05-12 2016-05-11 多量体タンパク質の純度の決定
JP2021092988A Active JP7137663B2 (ja) 2015-05-12 2021-06-02 多量体タンパク質の純度の決定
JP2022139802A Pending JP2022171730A (ja) 2015-05-12 2022-09-02 多量体タンパク質の純度の決定

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021092988A Active JP7137663B2 (ja) 2015-05-12 2021-06-02 多量体タンパク質の純度の決定
JP2022139802A Pending JP2022171730A (ja) 2015-05-12 2022-09-02 多量体タンパク質の純度の決定

Country Status (10)

Country Link
US (3) US10520511B2 (https=)
EP (2) EP3885368A1 (https=)
JP (3) JP7240812B2 (https=)
AR (1) AR104610A1 (https=)
AU (2) AU2016261854B2 (https=)
CA (1) CA2984010A1 (https=)
ES (1) ES2881359T3 (https=)
MA (2) MA56416A (https=)
PL (1) PL3294775T3 (https=)
WO (1) WO2016183222A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4434629A3 (en) 2015-11-30 2024-12-25 Intabio, Llc Methods for sample characterization
CN109937034B (zh) 2016-11-21 2022-09-16 济世-伊沃泰克生物制品有限公司 阿柏西普制剂及其用途
DK3668985T3 (da) 2017-08-17 2021-09-20 Just Evotec Biologics Inc Fremgangsmåde til rensning af glycosyleret protein fra værtscellegalectiner og andre urenheder
CA3081094A1 (en) 2017-11-20 2019-05-23 Alison J. GILLESPIE Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
WO2019148198A1 (en) 2018-01-29 2019-08-01 Intabio, Inc. Devices, methods and kits for sample characterization
EP3811397B1 (en) 2018-05-31 2024-09-18 Intabio, Llc Methods for interfacing microfluidic systems with mass spectrometry
PL3837282T3 (pl) * 2018-09-10 2026-02-16 Genentech, Inc. Układy i sposoby elektroforezy kapilarnej powinowactwa
US11573226B2 (en) 2018-09-10 2023-02-07 Genentech, Inc. Systems and methods for affinity capillary electrophoresis
US11782023B2 (en) * 2018-12-19 2023-10-10 Regeneron Pharmaceuticals, Inc. Ce-western applications for antibody development
CA3126712A1 (en) * 2019-01-31 2020-08-06 Regeneron Pharmaceuticals, Inc. Native microfluidic ce-ms analysis of antibody charge heterogeneity
US11285484B2 (en) 2019-08-12 2022-03-29 Intabio, Llc Multichannel isoelectric focusing devices and high voltage power supplies
US12594557B2 (en) 2019-08-12 2026-04-07 Intabio, Llc Isoelectric focusing devices and fixtures
EP4323761A1 (en) * 2021-04-14 2024-02-21 DH Technologies Development Pte. Ltd. Native fluorescence detection for protein analysis in capillary electrophoresis
JP2024544607A (ja) * 2021-11-25 2024-12-03 エフ. ホフマン-ラ ロシュ アーゲー 少量の抗体副産物の定量

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP385598A0 (en) * 1998-06-02 1998-06-25 Life Therapeutics Limited Purification of antibodies
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
JP4723725B2 (ja) * 1999-04-20 2011-07-13 ターゲット ディスカバリー, インコーポレイテッド 代謝経路を分析するための方法
US6818112B2 (en) * 1999-04-20 2004-11-16 Target Discovery, Inc. Protein separation via multidimensional electrophoresis
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
AUPQ743300A0 (en) * 2000-05-11 2000-06-01 Life Therapeutics Limited Separation of avian antibodies
SG106672A1 (en) 2002-03-08 2004-10-29 Asml Netherlands Bv Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method
US20090134028A1 (en) * 2005-09-22 2009-05-28 Chemicals Evaluation And Research Institute Method of Estimating Effect of Test Chemical on Living Organisms
EP1803814A1 (en) * 2005-12-27 2007-07-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Method of improving the antibody selection capacity in phage-display library
US9670269B2 (en) * 2006-03-31 2017-06-06 Chugai Seiyaku Kabushiki Kaisha Methods of modifying antibodies for purification of bispecific antibodies
WO2008151219A1 (en) 2007-06-04 2008-12-11 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
CN101874042B9 (zh) * 2007-09-26 2019-01-01 中外制药株式会社 利用cdr的氨基酸取代来改变抗体等电点的方法
JP4977588B2 (ja) * 2007-12-07 2012-07-18 富士フイルム株式会社 イムノクロマトグラフ方法
JP5816170B2 (ja) 2009-06-26 2015-11-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体
CA2836873C (en) * 2011-05-21 2019-10-22 Macrogenics, Inc. Deimmunized serum-binding domains and their use for extending serum half-life
GB2504139B (en) 2012-07-20 2014-12-31 Argen X Bv Antibodies to highly conserved targets produced by the immunisation of Camelidae species
EP2604624A1 (en) * 2011-12-13 2013-06-19 University College Dublin National University Of Ireland, Dublin Bowman-Birk protease Inhibitor (BBI) binding peptides, and uses thereof in the separation, detection or purification of BBI.
PT2825559T (pt) * 2012-03-13 2019-06-07 Novimmune Sa Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativo
RU2014153674A (ru) 2012-06-05 2016-07-27 Регенерон Фармасьютикалз, Инк. Способ получения полностью человеческих биспецифических антител с применением общей легкой цепи
TW202423993A (zh) * 2012-11-14 2024-06-16 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
CA2919174A1 (en) * 2013-08-19 2015-02-26 F. Hoffmann-La Roche Ag Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography
US11261262B2 (en) * 2013-09-03 2022-03-01 Novimmune Sa Readily isolated bispecific binding molecules with native format having mutated constant regions

Similar Documents

Publication Publication Date Title
JP2018528389A5 (https=)
JP2021152544A5 (https=)
JP7137663B2 (ja) 多量体タンパク質の純度の決定
JP2021152544A6 (ja) 多量体タンパク質の純度の決定
HRP20201634T1 (hr) Monoklonsko protutijelo protiv interleukina-31
IL275270A (en) Recombinant scavenger cell surface proteins
HRP20200464T1 (hr) Metoda modifikacije polipeptida za pročišćavanje polipeptidnih multimera
Biacchi et al. Analysis of monoclonal antibody by a novel CE‐UV/MALDI‐MS interface
JP2011217747A5 (https=)
JP2015529201A5 (https=)
EA201891410A1 (ru) Антитела к с5 и способы их применения
JP2018525333A5 (https=)
JP2015535344A5 (https=)
US20180172683A1 (en) Methods for analyzing the interaction between a target protein and a ligand
MY206255A (en) Humanized anti-vegf monoclonal antibody
JP2018520127A5 (https=)
MX2021014171A (es) Metodos para identificar y cuantificar proteinas de la celula huesped.
JP6157862B2 (ja) 標的物質−レセプター複合体と遊離レセプターとを分離する方法
ES3041610T3 (en) Systems and methods for affinity capillary electrophoresis
TW201144810A (en) Kits for RhD blood type determination and method for RhD blood type determination by using the same
蔡家烽 et al. Solid Phase TMT Labeling in HAMMOC Tip is a Solution to Increase the Recovery for Phosphoproteomics
UA130121U (uk) Спосіб прогнозування розвитку остеоартрозу
AR043718A1 (es) Anticuerpos monoclonales que se unen especificamente y con afinidad equivalente a todas las variantes glicosiladas de eritropoyetina recombinante humana, linea celular que los produce y metodo para la deteccion cuantitiva de eritropoyetina humana recombinante
HK1252480B (en) Multimeric protein purity determination
AR066471A1 (es) Metodo para desarrollar inmunoglobulinas